Evaluation Of Efficacy And Safety Of Prosman™ (Prunus Domestica Extract) On Prostate Function, Serum Testosterone Levels And Quality Of Life

ConditionHealthy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age40-60
SponsorAll India Institute of Medical Sciences, Bhubaneswar

About this trial

This study is designed to test the safety and effectiveness of a plant-based supplement called Prosman™ (made from Prunus domestica extract) for men with symptoms of benign prostate hyperplasia (BPH), a common non-cancerous enlargement of the prostate gland that causes urinary problems in older men.

Key Points:

Purpose: The main goal is to see if Prosman™ can improve prostate health, hormone levels, and quality of life in men aged 40 to 60 who have BPH symptoms.

How the Study Works:

38 men will be randomly assigned to take either Prosman™ or a placebo (a dummy pill) every day for 8 weeks.

The study is randomized and controlled, meaning neither the participants nor the researchers know who is getting Prosman™ or the placebo.

Measurements:

Prostate health will be measured using a symptom score.

Blood tests will check hormone levels and other health markers.

Quality of life will also be tracked.

Safety: The study will monitor for any side effects or health problems during the trial.

Why It Matters: Current medications for BPH can have unwanted side effects, so there is interest in plant-based alternatives like Prosman™, which may offer benefits with fewer risks.

The study follows strict ethical guidelines to protect participants' privacy and safety. Data will be kept confidential, and participants can leave the study at any time.

Eligibility criteria

Qualifiers

Provide voluntarily signed and dated informed consent.

Be in good health as determined by medical history and routine blood chemistries.

Age between 40 and 60 yr (inclusive).

Body Mass Index of 18.5-34.9 (inclusive).

Disqualifiers

Current neurogenic bladder dysfunction.

Current bladder neck contracture or urethral stricture.

Current acute or chronic prostatitis or UTI.

History of prostate cancer.

Trial design

Treatments tested in this trial

  • Prosman
  • Placebo

Treatment groups

38 Participants
are divided into 2 treatment groups

Locations

This trial has no locations